Integrated Technology Commercialization

In our previous article on Technologie-Fatigue, we described the challenge of standing out in the market with new technology offerings and generating genuine customer preference. In this article, we now introduce the approach we use to address this challenge throughout the innovation process, laying the foundation for successful commercialization.

This is particularly relevant for healthcare products and solutions, where procurement and integration are especially complex, and every potential innovation is weighed against the substantial effort required for adoption. MedTech companies are often highly capable of further developing existing products, both hardware and software, ensuring regulatory compliance, and bringing them to market through established sales channels. For products and services that first need to be established in the market, however, it is especially challenging to make their value clear, credible, and compelling.

It is not enough to first develop a solution, then obtain approval, and only afterwards “do some marketing.” Market acceptance does not emerge as a downstream activity; it needs to be anticipated early and actively built: through a clear understanding of clinical needs, robust positioning, suitable evidence, and the right partnerships.

This is the concept behind our “Integrated Technology Commercialization” approach: supporting the entire innovation process, it connects product development with clinical practice and the market, helping to turn technological performance into a solution that is understood and adopted in the market.

So, what are the key building blocks of integrated technology commercialization?

1) Strategic Positioning

Especially for novel products and services, it is important to understand the specific use context in detail to achieve the greatest possible clinical benefit. The key question is not whether a technology works, but how it creates value in clinical practice: Which workflows does it change? Who benefits? Who takes on additional effort, responsibility, or risk?

Clarifying these questions early and connecting technology, medical practice, and business realities reduces the risk of costly strategic missteps. Product decisions, evidence generation, and communication need to be aligned with market requirements before technical, regulatory, or commercial path dependencies become locked in.

2) Evidence, Stakeholders, and Validation

For medical applications, evidence is of course a regulatory requirement, but also a key lever for trust, adoption, and reimbursement. Clinical studies, as well as white papers or case studies, are only truly valuable from a market strategy perspective if they answer the questions that users, decision-makers, or payers will actually ask. In the market, it is not automatically the technically best solution that wins, but the one whose value is understood and seen as credible.

Throughout the innovation process, the relevant evidence therefore needs to be generated through the deliberate development of clinical networks, active stakeholder management, and well-coordinated pilot projects, so that robust data and credible claims can emerge in the market.

3) Communication, Trust, and Preference

Many companies communicate in a way that is technologically accurate but interchangeable: rich in product features, yet at times with limited relevance to concrete purchasing decisions. But even in B2B settings, people make decisions under uncertainty, with personal responsibility, and based on trust. Successful technology commercialization therefore creates confidence in decision-making and preference. It translates technical performance into a strong answer to the question: Why is this solution relevant, and why should we choose this one?

This also includes an emotional dimension: innovation needs to resonate with its target audiences and create a sense of relevance and appeal. The key to this is a credible narrative that provides orientation, establishes differentiation, and directly supports purchasing decisions.

Conclusion

Integrated technology commercialization aligns innovations with market success from the outset. It connects clinical understanding, strategic positioning, targeted evidence and network development, and focused marketing into a combined development and commercialization approach.

It goes well beyond traditional marketing communication: its aim is not merely to present a finished product attractively, but to take relevant market requirements and innovation risks into account early, build the right evidence, and actively drive successful market adoption.

Please feel free to contact us at Synwisery to discuss how we can address your commercialization challenges together.

Natalie Erdmann & Dr. Stefan Braunewell
Managing Partners